NCT06017999View on ClinicalTrials.gov

XG005 for Pain Control in Subjects Undergoing Bunionectomy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

August 29, 2023

Primary Completion Date

August 29, 2024

Study Completion Date

September 30, 2024

Conditions
Acute Pain
Interventions
DRUG

XG005 tablet

Subjects will receive XG005 prior to surgery and every 12 hours for 72 hours.

DRUG

Placebo tablet

Subjects will receive placebo prior to surgery and every 12 hours for 72 hours.

Trial Locations (8)

33014

Clinical Pharmacology of Miami, Hialeah

45417

Midwest Clinical Research Center, Dayton

75006

Legent Orthopedic Hospital, Carrollton

77043

Memorial Hermann Village, Houston

77401

First Surgical Hospital, Bellaire

78229

Endeavor Clinical Trials, San Antonio

85053

Arizona Research Center, Phoenix

92128

Pacific Research Network, San Diego

All Listed Sponsors
lead

Xgene Pharmaceutical Group

INDUSTRY